Home › Compare › GZUHF vs ABBV
GZUHF yields 869.57% · ABBV yields 3.06%● Live data
📍 GZUHF pulled ahead of the other in Year 1
Combined, GZUHF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GZUHF + ABBV for your $10,000?
Guangzhou R&F Properties Co., Ltd., together with its subsidiaries, engages in the development and sale of residential and commercial properties in the People's Republic of China, Malaysia, Cambodia, Korea, the United Kingdom, and Australia. The company invests in and develops various properties, including hotels, office buildings, shopping malls, logistics parks, and other retail properties in Beijing, Guangzhou, and other cities; and engages in construction business. It is also involved in the operation and management of hotels and a theme park under the Hainan R&F Ocean Paradise name; provides property management and leasing, and architectural and engineering design services, as well as marketing development services; and operates a football club. In addition, the company operates offline exhibition and trading complex; and offers online ecological industry operation platform services. Further, it operates diet, healthcare, sports, and culture and entertainment centers; and a hospital that provides prevention and healthcare, health assessment and management, diagnosis, treatment, and rehabilitation services, as well as elderly care services. Additionally, the company provides planning and designing, supervision, construction, landscaping, electrical and service installation, and interior decoration services. It also engages in the design and consulting of buildings and urban planning projects; installation of electromechanical and crane equipment, fire-fighting facilities, intelligent construction, power supply, and distribution projects. As of December 31, 2021, the company operated 93 deluxe hotels. Guangzhou R&F Properties Co., Ltd. was founded in 1994 and is headquartered in Guangzhou, the People's Republic of China.
Full GZUHF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.